1.	Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 1/05, NCT00450645
2.	Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RC08/118, NCT01356329
3.	ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER. Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Unipg-CRU-01-2012, NCT01589146
4.	Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RV-MM-PI-0345, NCT01380106
5.	National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients Phase: No phase specified Type: Natural history/Epidemiology Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Version N°2.0 du 21/03/2011, NCT01362933
6.	Heparin Solution and INTEM/HEPTEM Analysis Phase: No phase specified Type: Diagnostic Status: Active Age: 20 and over Sponsor: Other Protocol IDs: B_1112_069_003, NCT01522846
7.	Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: OSU-10055, NCI-2012-00894, NCT01696760
8.	Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer Phase: No phase specified Type: Natural history/Epidemiology, Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: Tropique, NCT01803022